The Department of Radiation Oncology is in the new Perelman Center. Occupying approximately 80,000 square feet on the Concourse Level, the new treatment facilities includes the most advanced proton and conventional radiation treatment modalities available as well as public spaces designed for the highest levels of patient comfort.
Over 50% of the new cancer cases in the world arise in low and middle-income countries such as Botswana, and this is expected to rise to 70% by 2030. In Sub-Saharan Africa, the high prevalence of HIV further complicated the situation. For example, over 80% of the cervical cancer patients in Botswana are HIV-positive. The treatment of these patients is too often unguided. Other major issues include the lack of human resources, high-level training, and technology.
1) CLINICAL CARE: UPENN Radiation Oncology faculty will be based in Botswana to help standardize treatments and improve clinical care. They will also be working on developing a cancer follow-up program and integrating the oncology clinic with the cervical cancer-screening program at BUP to limit treatment delays.
2) CLINICAL DIDACTIC VISITS: UPENN Radiation Oncology faculty with oncology site specific expertise will be visiting to provide didactic tutorials in needed focus areas especially pertinent to Botswana (e.g. cervical cancer, brachytherapy, palliative care, lymphoma, head and neck cancer, medical physics, etc.)
3) CLINICAL EDUCATION: UPENN faculty, residents, and fellows will work with the Botswana MOH and UB to help develop oncology training curriculum for students. In addition, senior UPENN Radiation Oncology residents will rotate at the Radiation Oncology Clinic in Gaborone to help with clinical work, help teach UB students and residents, while also expanding their own clinical experience. Starting 8/1/2014, we will be accepting applications for 1-2 month clinical rotations in Botswana.
4) NURSING EDUCATION: UPENN Radiation Oncology nursing staff will facilitate oncology nursing training and help develop nursing education modules with special relevance to oncology in Botswana.
5) PATIENT EDUCATION: UPENN faculty, residents, fellows, and nursing staff will develop patient education modules focusing on importance of screening, treatment and toxicities.
6) CLINICAL RESEARCH: UPENN will be collaborating with UB and BUP on research into virally-mediated cancers, with a special focus on cervical cancer natural history and treatment outcomes in HIV-positive patients..
7) LOW COST TECHNOLOGIES: Collaborations are sought throughout the UPENN community (Schools of Engineering, Education, Business, Nursing, or Epidemiology) to help develop much needed low cost resources, tools and technologies for improved cancer screening, diagnosis, and treatment..
For more information, please contact
Surbhi Grover, MD, MPH